Literature DB >> 16996710

Idiopathic hypereosinophilic syndrome complicated by central sinovenous thrombosis.

Ryoichi Sakuta1, Yuzo Tomita, Makiko Ohashi, Toshiro Nagai, Nobuyuki Murakami.   

Abstract

Idiopathic hypereosinophilic syndrome (IHES) is a rare disorder affecting cardiac, pulmonary and nervous systems with peripheral neuropathy, encephalopathy and cerebral thromboembolism. We report a 7-year-old boy with IHES who developed central sinovenous thrombosis and cerebral hemorrhage. Although he had hypereosinophilia for more than 6 months, he was asymptomatic until the sudden onset of vomiting and headache due to superior sagittal sinus thrombosis. Molecular analysis in peripheral blood did not reveal any mutation in the Fip1-like-platelet-derived growth factor receptor alpha chain (FIP1L1-PDGFRA) gene which was recently reported to be mutated in IHES. Since there must be symptoms or signs of organ involvement to fulfill the IHES criteria, we could not make a diagnosis of IHES until the onset of central nervous system involvement. We suggest that anti-coagulant therapy should be considered for asymptomatic patients with hypereosinophilia because hypereosinophilia may induce thrombosis in various organs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996710     DOI: 10.1016/j.braindev.2006.08.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

Review 1.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

2.  Idiopathic hypereosinophilic syndrome presenting with liver mass: Report of two cases: Idiopathic hypereosinophilic syndrome and liver mass.

Authors:  Kamran Shatery; Alireza Sayyah
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

3.  A case of hypereosinophilic syndrome presenting with multiorgan thromboses associated with intestinal obstruction.

Authors:  Tao Sui; Qing Li; Li Geng; Xinnv Xu; Yuming Li
Journal:  Turk J Haematol       Date:  2013-09-05       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.